CLARIFY - Trademark Details
Status: 641 - Non-Final Action - Mailed
Image for trademark with serial number 90836111
Serial Number
90836111
Word Mark
CLARIFY
Status
641 - Non-Final Action - Mailed
Status Date
2022-02-09
Filing Date
2021-07-19
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Law Office Assigned Location Code
O30
Employee Name
LOOK, JEFFREY J
Statements
Goods and Services
Rapid lateral flow assays; Real time Polymerase Chain Reaction Medical diagnostic tests; Real time Polymerase Chain Reaction lyophilized products for laboratories; Polymerase Chain Reaction assays; Lower nostril nasal swab for detection of infectious disease; Nasopharyngeal tests for detection of infectious disease; Medical diagnostic test for detection of nucleic acid from SARS-CoV-2; Diagnostic tests for detection of infectious diseases on surfaces; Medical diagnostic test strips, cassette, trays, and devices for infectious disease; Medical diagnostic test strips, cassette, trays, and devices for infectious disease for point of care, laboratory, and home use; Rapid medical diagnostic test strips, cassette, trays, and devices for infectious disease; Medical diagnostic tests for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Cell-based medical diagnostic tests for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Rapid medical diagnostic tests for Influenza A, Influenza B, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses; Medical diagnostic tests for Influenza A, Influenza B, SARS, Covid-19, SARS-CoV-2, Coronavirus, and respiratory illnesses for point of care, laboratory, and home use; Medical diagnostic antigen tests; Rapid medical diagnostic antigen tests; Medical diagnostic antigen tests for point of care, laboratory, and home use; Medical diagnostic tests for oncology; Rapid medical diagnostic tests for oncology; Medical diagnostic tests for oncology for point of care, laboratory, and home use; Medical diagnostic tests for cardiac markers; Medical diagnostic antibody tests; Rapid medical diagnostic antibody tests; Medical diagnostic antibody tests for point of care, laboratory, and home use; Medical diagnostic vitamin D tests; Rapid medical diagnostic vitamin D tests; Medical diagnostic vitamin D tests for point of care, laboratory, and home use; Medical diagnostic opioid tests; Rapid medical diagnostic opioid tests; Medical diagnostic opioid tests for point of care, laboratory, and home use; Testing kits comprised of medical devices and diagnostic reagents and assays for testing bodily fluids, blood, DNA, RNA, and skin; Testing kits comprised of medical devices and diagnostic reagents and assays for rapid testing bodily fluids, blood, DNA, RNA, and skin; Testing kits comprised of medical devices and diagnostic reagents and assays for testing bodily fluids, blood, DNA, RNA, and skin for point of care, laboratory, and home use; Medical diagnostic tumor tests; Rapid medical diagnostic tumor tests; Medical diagnostic tumor tests for point of care, laboratory, and home use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease and virus detection; Diagnostic kits comprised of medical diagnostic reagents and assays for rapid testing of bodily fluids for use in disease and virus detection; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease and virus detection for point of care, laboratory, and home use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease and virus detection for animals; Reporting qualitative and quantitative medical diagnostic test results; Medical diagnostic testing services; Medical testing for diagnostic or treatment purposes; Rapid, single-use molecular diagnostic test kit for the qualitative detection of SARS-CoV-2 RNA from self-collected nasal swab specimens; Rapid, single-use molecular diagnostic test kit for the qualitative detection of SARS-CoV-2 RNA with isothermal amplification (LAMP) and test results displayed via LED indicators; Rapid, single-use molecular diagnostic test kit for the qualitative detection of SARS-CoV-2 RNA with Positive Internal Control (PIC) and Lysis Internal Control (LIC) contained within the test unit; Syndromic infections disease tests; Syndromic infections disease tests for severe acute respiratory syndrome; Nucleic acid test for qualitative detection of respiratory viral and bacterial nucleic acids; In vitro immunochromatographic assay for the direct qualitative detection of Sars - Cov 2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions; Analysis of nucleic acids and run temperature cycles enabling DNA and RNA detection using qPCR and isothermal amplifications; Antibody detection of anti-Sars-COV-2 IgM and anti Sars - COV-2 OgG in human blood, serum or plasma; Antigen test, namely, immunochromatographic assay for the detection of the viral nucleoprotein; RT-PCR (Reverse-transcription polymerase chain reaction) tests; Transcription-mediated amplification (TMA) tests; Interactive Skin test to measure T-Cell Immunity
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-09-21
Primary Code
005
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Courtney Thompson
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2021-07-22NEW APPLICATION ENTERED IN TRAM
2021-09-21NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2021-07-28TEAS VOLUNTARY AMENDMENT RECEIVED
2021-07-28TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
2022-02-08ASSIGNED TO EXAMINER
2022-02-09NON-FINAL ACTION WRITTEN
2022-02-09NON-FINAL ACTION E-MAILED
2022-02-09NOTIFICATION OF NON-FINAL ACTION E-MAILED